CClinicalTrials.gg
CompletedNCT03420001Updated Aug 9, 2021

Vaginal Birth After Caesarean Section and Levator Ani Avulsion

An observational study in Birth Injuries, sponsored by Charles University, Czech Republic. Completed at 2 sites in Czechia. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-09.

Sponsored by Charles University, Czech Republic · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
469
Ages
18 Years and older
Sex
Female
01

Study summary

There is no data regarding the risk of levator ani avulsion in women after a vaginal birth after caesarean although a possible increased risk has been suggested. The aim of the study is to describe the incidence of levator ani avulsion and compare it to primiparous women. In addition, health related quality of life will be evaluated and compared

Read the detailed description

Levator ani muscle avulsion is a frequent postpartum trauma imposing a considerable risk of pelvic organ prolapse on women in later life. Furthermore, the trauma reduces the effectiveness of pelvic reconstructive surgery and has a detrimental effect of the sexuality of the affected women. The trauma occurs most frequently in the first vaginal delivery with an incidence of 10-30%. However, the risk of levator avulsion in women after vaginal birth after caesarean section (VBAC) is unknown although possible increased risk has been suggested.

The aim of the study is to assess the prevalence of levator ani avulsion among women who delivered vaginally after a caesarean section and make a comparison with a primiparous cohort. The secondary aim is to evaluate and compare the health related quality of life regarding pelvic floor disorders and sexuality.

02

Conditions studied

  • Birth Injuries

Keywords

  • VBAC, levator ani avulsion, quality of life
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Sampling method
Probability sample

Study population

Women at least 6 months after the first vaginal delivery with or without a caesarean section in their history.

Inclusion criteria

  • one term vaginal delivery in obstetric history
  • agreement with the enrollment

Exclusion criteria

Exclusion Criteria:

  • Women with a history of repeat VBAC or a vaginal delivery prior to the index caesarean section
  • women with preterm labor
  • epidural analgesia
  • multiple pregnancy
  • dead or malformed fetus
04

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
469 participants (actual)
Patient registry
No

Groups and cohorts

  • VBAC

    secundiparous women after one vaginal birth after caesarean section

  • controls

    women after one vaginal delivery

05

What researchers measure

Primary outcomes

  1. Levator ani avulsion

    Presence of levator ani avulsion diagnosed by offline tomographic ultrasound imaging of an ultrasound volume of the pelvic floor

    Time frame: at least 6 months after the delivery

  2. Genital hiatus ballooning

    Area of the urogenital hiatus over 25cm2 during maximal Valsalva

    Time frame: at least 6 months after the delivery

Secondary outcomes

  1. Pelvic floor dysfunction

    Pelvic Floor Distress Inventory - PFDI-20 - shortened form of a validated questionnaire evaluating quality of life with pelvic floor disorders (pelvic organ prolapse, urinary incontinence, anal incontinence) evaluation of subscales POPDI-6, UDI-6, CRADI-8 (scale 0-100 in all subscales, the higher the number the higher the impact)

    Time frame: at time of the ultrasound examination

  2. Anal incontinence

    Scoring of the severity of anal incontinence using the St. Mark's score - scoring system (0 - perfect continence, maximum score 24 - totally incontienent.

    Time frame: at time of the ultrasound examination

  3. Sexuality

    Evaluation of sexuality using validated Czech translation of the Pelvic Organ Prolapseand incontinence sexual questionnaire - internationally revised (PISQ-IR) - analysis of individual domains via subscores (NSA-CS, NSA-PR, NSA-GQ, NSA-CI or SA-AO, SA-PR, SA-CS, SA-GQ, SA-D, SA-CI. Transformed score 0-100 for each subscore.

    Time frame: at time of the ultrasound examination

06

Study locations

2 sites
  • Department of Obstetrics and Gynecology, Medical Faculty in Pilsen, Charles University Hospital
    Pilsen, 30460, Czechia
  • Department of Obstetrics and Gynecology, 1st Medical Faculty, Charles University Hospital
    Prague, 12808, Czechia
07

References and documents

Publications

  • Horak TA, Guzman-Rojas RA, Shek KL, Dietz HP. Pelvic floor trauma: does the second baby matter? Ultrasound Obstet Gynecol. 2014 Jul;44(1):90-4. doi: 10.1002/uog.13252. Epub 2014 May 23. PubMed 24311466 ↗
  • Albrich SB, Laterza RM, Skala C, Salvatore S, Koelbl H, Naumann G. Impact of mode of delivery on levator morphology: a prospective observational study with three-dimensional ultrasound early in the postpartum period. BJOG. 2012 Jan;119(1):51-60. doi: 10.1111/j.1471-0528.2011.03152.x. Epub 2011 Oct 10. PubMed 21985531 ↗
  • Dietz HP, Bernardo MJ, Kirby A, Shek KL. Minimal criteria for the diagnosis of avulsion of the puborectalis muscle by tomographic ultrasound. Int Urogynecol J. 2011 Jun;22(6):699-704. doi: 10.1007/s00192-010-1329-4. Epub 2010 Nov 24. PubMed 21107811 ↗
  • Dietz HP, Shek C, De Leon J, Steensma AB. Ballooning of the levator hiatus. Ultrasound Obstet Gynecol. 2008 Jun;31(6):676-80. doi: 10.1002/uog.5355. PubMed 18470963 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03420001
Lead sponsor
Charles University, Czech Republic
Responsible party
Zdenek Rusavy (Principal Investigator, Charles University, Czech Republic) — Principal investigator
First posted
Feb 5, 2018
Start date
Aug 2, 2017
Primary completion
Aug 30, 2020
Completion
Dec 10, 2020
Last update
Aug 9, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion